⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3407152 | 1.00 | — | — | |
| SCHEMBL16585834 | 1.00 | — | — | |
| SCHEMBL2004047 | 0.93 | ARG1 (0.33) | — | |
| SCHEMBL13762916 | 0.81 | — | — | |
| SCHEMBL22793161 | 0.79 | — | — | |
| SCHEMBL3448254 | 0.76 | HCAR2 (0.34) | — | |
| SCHEMBL19718510 | 0.76 | ARG1 (0.30) | — | |
| SCHEMBL27872502 | 0.74 | CYP2D6 (0.31) | — | |
| SCHEMBL27486977 | 0.72 | NSD2 (0.35) | — | |
| SCHEMBL28495057 | 0.70 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 97 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118984715-A | Compositions for the treatment of macular degeneration comprising novel peptides | 韩国视角生物株式会社 | 2024-11-19 | — | — | CN | claimed |
| EP-4450079-A1 | COMPOSITION FOR TREATING MACULAR DEGENERATION COMPRISING NOVEL PEPTIDE | EyebioKorea, Inc. (KR) | 2024-10-23 | — | — | EP | claimed |
| CN-118406404-A | Circuit board ink-jet printing ink stripping agent and preparation method and application thereof | 珠海市板明科技有限公司 | 2024-07-30 | — | — | CN | claimed |
| WO-2023113300-A1 | COMPOSITION FOR TREATING MACULAR DEGENERATION COMPRISING NOVEL PEPTIDE | 주식회사 아이바이오코리아 | 2023-06-22 | — | — | WO | claimed |
| EP-3914068-A1 | COMPOSITIONS FOR TREATING CITRUS DISEASE AND PROMOTING YIELD INCREASE IN ROW CROPS | Spogen Biotech Inc. (US) | 2021-12-01 | — | — | EP | claimed |
| CN-113395898-A | Compositions for treating citrus disease and promoting yield enhancement of row crops | 斯波根生物技术公司 | 2021-09-14 | — | — | CN | claimed |
| US-20200255851-A1 | COMPOSITIONS FOR TREATING CITRUS DISEASE AND PROMOTING YIELD INCREASE IN ROW CROPS | GENISYS CREDIT UNION | 2020-08-13 | — | — | US | claimed |
| WO-2020154387-A1 | COMPOSITIONS FOR TREATING CITRUS DISEASE AND PROMOTING YIELD INCREASE IN ROW CROPS | SPOGEN BIOTECH INC. (US) | 2020-07-30 | — | — | WO | claimed |
| EP-3606347-A1 | AGRICULTURAL COMPOSITIONS FOR IMPROVED CROP PRODUCTIVITY AND ENHANCED PHENOTYPES | Spogen Biotech Inc. (US) | 2020-02-12 | — | — | EP | claimed |
| WO-2018187345-A1 | AGRICULTURAL COMPOSITIONS FOR IMPROVED CROP PRODUCTIVITY AND ENHANCED PHENOTYPES | SPOGEN BIOTECH INC. (US) | 2018-10-11 | — | — | WO | claimed |
| WO-2005116055-A1 | PEPTIDES, ANTIBODIES AND COMPOSITIONS CONTAINING SAME USEFUL FOR TREATING HIV VIRUS INFECTION | YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM (IL) | 2005-12-08 | — | — | WO | claimed |
| US-5658885-A | OLIGOPEPTIDES; ANTICOAGULANTS; ENZYME INHIBITORS; THROMBIN | THE DUPONT MERCK PHARMACEUTICAL COMPANY (US) | 1997-08-19 | — | — | US | claimed |
| US-12428446-B2 | Peptide compound or pharmaceutically acceptable salt thereof | EYEBIO KOREA (KR) | 2025-09-30 | — | — | US | disclosed |
| US-20250241300-A1 | AGRICULTURAL COMPOSITIONS FOR IMPROVED CROP PRODUCTIVITY AND ENHANCED PHENOTYPES | SPOGEN BIOTECH INC. | 2025-07-31 | — | — | US | disclosed |
| US-20250236878-A1 | COMPOSITIONS FOR TREATING CITRUS DISEASE AND PROMOTING YIELD INCREASE IN ROW CROPS | SPOGEN BIOTECH INC. | 2025-07-24 | — | — | US | disclosed |
| WO-2025104264-A1 | HCRHR2 SELECTIVE POLYPEPTIDES | Gubra A/S (DK) | 2025-05-22 | — | — | WO | disclosed |
| WO-2001040262-A1 | ALPHA-KETOAMIDE INHIBITORS OF HEPATITIS C VIRUS NS3 PROTEASE | BRISTOL-MYERS SQUIBB PHARMA COMPANY (US) | 2001-06-07 | — | — | WO | disclosed |
| US-5658885-A | OLIGOPEPTIDES; ANTICOAGULANTS; ENZYME INHIBITORS; THROMBIN | THE DUPONT MERCK PHARMACEUTICAL COMPANY (US) | 1997-08-19 | — | — | US | disclosed |
| EP-0787010-A1 | AMIDINO AND GUANIDINO SUBSTITUTED INHIBITORS OF TRYPSIN-LIKE ENZYMES | THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) | 1997-08-06 | — | — | EP | disclosed |
| WO-1996012499-A1 | AMIDINO AND GUANIDINO SUBSTITUTED INHIBITORS OF TRYPSIN-LIKE ENZYMES | THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) | 1996-05-02 | — | — | WO | disclosed |